Literature DB >> 1963884

Effect of modification of HEp 2 cell membrane lipidic phase on susceptibility to infection from herpes simplex virus.

F Galdiero1, A Folgore, M Galdiero, M A Tufano.   

Abstract

We have verified the consequences of alterations of the lipidic phase of HEp 2 cell membranes on susceptibility to infection from Herpes simplex virus, and have related these results to modification in membrane fluidity. This was carried out by treating HEp 2 cells with saturated and unsaturated fatty acids with chain lengths from eight to 18 carbon atoms. The results show that HEp 2 cells treated with saturated fatty acids with eight and ten carbon atoms have both increased membrane fluidity and increased susceptibility to Herpes simplex virus infection while both parameters were reduced when HEp 2 cells were treated with saturated fatty acids having 14 and 18 carbon atoms. Fatty acids with 16 carbon atoms, however, show an increase in membrane fluidity which has no significant correlation to infection susceptibility. As to unsaturated acids, those with eight carbon atoms, 2-octenoic acid (trans-8: 1[2]) and 2-octynoic acid (8:::1[2]), increase the susceptibility to infection and fluidity while low concentrations of monounsaturated acids with 14 and 18 carbon atoms, myristoleic acid (cis-14:1[9]) and oleic acid (cis-18:1[9]), reduce both the susceptibility to infection and the fluidity of the membrane.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963884     DOI: 10.1007/bf01646411

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Further characterization of the impaired protective function in mice fed with lipid diet.

Authors:  F Galdiero; C Romano Carratelli; I Nuzzo; C Bentivoglio; E Galdiero
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

2.  Rotational relaxation time of concanavalin A bound to the surface membrane of normal and malignant transformed cells.

Authors:  M Inbar; M Shinitzky; L Sachs
Journal:  J Mol Biol       Date:  1973-12-05       Impact factor: 5.469

3.  Phospholipid metabolism of herpesvirus-infected and uninfected rabbit kidney cells.

Authors:  T Ben-Porat; A S Kaplan
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

4.  Newcastle disease virus-induced plasma membrane damage.

Authors:  J Katzman; D E Wilson
Journal:  J Gen Virol       Date:  1974-07       Impact factor: 3.891

5.  Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells.

Authors:  M Shinitzky; M Inbar
Journal:  J Mol Biol       Date:  1974-01-05       Impact factor: 5.469

6.  Gross structural changes in isolated liver cell plasma membranes upon binding of insulin.

Authors:  P Luly; M Shinitzky
Journal:  Biochemistry       Date:  1979-02-06       Impact factor: 3.162

7.  Microviscosity parameters and protein mobility in biological membranes.

Authors:  M Shinitzky; M Inbar
Journal:  Biochim Biophys Acta       Date:  1976-04-16

8.  Increase in lipid fluidity of cellular membranes induced by adsorption of RNA and DNA virions.

Authors:  A Levanon; A Kohn; M Inbar
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

9.  The correlation of fatty acid content of infected cells and virions with Newcastle disease virus (NDV) virulence.

Authors:  J I Blenkharn; K Apostolov
Journal:  J Gen Virol       Date:  1981-02       Impact factor: 3.891

10.  13C-NMR studies of the membrane structure of enveloped virions (vesicular stomatitis virus).

Authors:  W Stoffel; K Bister; C Schreiber; B Tunggal
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-07
View more
  1 in total

1.  Metabolic features of chronic fatigue syndrome.

Authors:  Robert K Naviaux; Jane C Naviaux; Kefeng Li; A Taylor Bright; William A Alaynick; Lin Wang; Asha Baxter; Neil Nathan; Wayne Anderson; Eric Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.